Health and Healthcare
Health and Healthcare Articles
Deciphera Pharma shares nearly doubled on Tuesday after the firm announced top-line results from its late-stage trial treating patients with gastrointestinal stromal tumors.
Published:
24/7 Wall St. has evaluated all pharmaceutical and biotech companies that pay dividend yields above 2% based on their current prices.
Published:
Last Updated:
Alzheimer’s disease and other forms of dementia are a growing worldwide health problem, affecting some 50 million people around the globe, and it’s getting worse. An estimated 10 million people...
Published:
Short sellers seem to have many emerging and speculative biotech stocks targeted for termination. Here are eight of them against which short sellers are betting the farm.
Published:
Last Updated:
People who come into contact with toxic lake water, either by accident or poor judgment, can face extremely severe health consequences.
Published:
The July 31 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Published:
Last Updated:
The July 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
Amarin shares dropped on Friday after the firm announced that it received notice from the FDA that delays a pending supplemental new drug application.
Published:
Last Updated:
Most Americans have never heard of one of the most common forms of skin cancer — one that’s about five times more common than melanoma, and is estimated to kill about twice as many people...
Published:
DBV Tech shares shot up on Thursday after the company announced the submission of paperwork to the FDA for Viaskin Peanut for the treatment of peanut-allergic children.
Published:
Rhythm Pharma shares jumped on Wednesday after the company announced positive results from two of its late-stage obesity clinical trials.
Published:
Insulet shares surged after it reported earnings. The company's Omnipod insulin management system saw stellar growth in sales.
Published:
Minerva Neurosciences shares jumped on Monday after the company announced positive topline results from its two mid-stage studies in major depressive disorder (MDD) and insomnia. Specifically, these...
Published:
One primary reason that longevity in the United States has grown for decades is more effective treatments for cardiovascular disease. The period of progress may have ended though, according to a new...
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.